| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/25/2005 | US20050186217 Compositions produced using enteric pathogens and methods of use |
| 08/25/2005 | US20050186215 CUDR as biomarker for cancer progression and therapeutic response |
| 08/25/2005 | US20050186212 Trefoil factor 3 (TFF3) as a target for anti-cancer therapy |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186210 Method for tissue regeneration |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186201 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 08/25/2005 | US20050186199 An antibody directed against particular amino acid regions of Hsp70B' and its preparation by administering a peptide corresponding, or antigenically equivalent, to those regions; detection of the stress-inducible Hsp70B' protein |
| 08/25/2005 | US20050186187 Altering the expression levels of a protein; modulating the activity of secretory leukocyte protease inhibitor (SLPI), CD53, or Transferrin-1 in a cell and culturing the cells |
| 08/25/2005 | US20050186185 Mammalian cell modified with genes encoding plant late embryogenesis protein HVA1, trehalose transport protein, or a trehalose synthesis pathway; freezing and/or drying organs for storage prior to use |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186179 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/25/2005 | US20050186146 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 08/25/2005 | US20050185135 Electro-active spectacle employing modal liquid crystal lenses |
| 08/25/2005 | CA2849552A1 Hybrid polypeptides with selectable properties |
| 08/25/2005 | CA2601952A1 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor using the same |
| 08/25/2005 | CA2559359A1 Identification of snps associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism |
| 08/25/2005 | CA2556739A1 Pharmaceutical composition for treatment of immunological disorders |
| 08/25/2005 | CA2556711A1 Preparation of canola protein isolate and use in aquaculture |
| 08/25/2005 | CA2555894A1 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 08/25/2005 | CA2555877A1 Hybrid polypeptides with selectable properties |
| 08/25/2005 | CA2555393A1 Hybrid proteins of active-site serine beta-lactamase |
| 08/25/2005 | CA2555274A1 Chimeric vegf peptides |
| 08/25/2005 | CA2555253A1 Compositions of pamps and listeria monocytogenes and methods of use |
| 08/25/2005 | CA2555144A1 Methods of treating skin disorders |
| 08/25/2005 | CA2554999A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2554089A1 Albumin fusion proteins |
| 08/25/2005 | CA2553703A1 Ornithobacterium rhinotracheale subunit vaccines |
| 08/25/2005 | CA2550401A1 Method and compositions for detecting botulinum neurotoxin |
| 08/25/2005 | CA2549432A1 Lipid rafts and clostridial toxins |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566444A2 Yield-related genes |
| 08/24/2005 | EP1566440A2 Human Interleukin-11 Receptor |
| 08/24/2005 | EP1566439A1 Preventing or treating obesity |
| 08/24/2005 | EP1566438A2 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566386A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1565754A2 New uses of proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/24/2005 | EP1565749A2 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/24/2005 | EP1565744A2 Microarrays of cellulose binding chimeric proteins and methods of use thereof |
| 08/24/2005 | EP1565583A2 Hiv vaccine formulations |
| 08/24/2005 | EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565577A1 Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts |
| 08/24/2005 | EP1565571A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 08/24/2005 | EP1565559A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 08/24/2005 | EP1565557A2 Mismatch endonucleases and methods of use |
| 08/24/2005 | EP1565552A2 Esm-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same |
| 08/24/2005 | EP1565548A2 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| 08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/24/2005 | EP1565488A2 Cancer-linked gene as target for chemotherapy |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565486A2 Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine |
| 08/24/2005 | EP1565482A2 A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same |
| 08/24/2005 | EP1565217A2 Chemically-modified human growth hormone conjugates |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565211A2 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 08/24/2005 | EP1565207A2 Prekallikrein depleted plasma derived albumin fraction |
| 08/24/2005 | EP1565205A2 Interferon-alpha polypeptides and conjugates |
| 08/24/2005 | EP1565203A2 Templated native silk smectic gels |
| 08/24/2005 | EP1565202A2 Methods for the treatment of alzheimer's disease and compositions therefore |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 08/24/2005 | EP1565080A2 Novel immunogenic proteins of leptospira |
| 08/24/2005 | EP1492440A4 A new method for the diagnosis and prognosis of malignant diseases |
| 08/24/2005 | EP1461078A4 A PEPTIDE-BASED FLUORESCENCE POLARIZATION ASSAY FOR DETECTION OF ANTIBODIES TO i MYCOBACTERIUM BOVIS /i |
| 08/24/2005 | EP1451207A4 Labeling reagent and methods of use |
| 08/24/2005 | EP1421104A4 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 08/24/2005 | EP1358356A4 Dna markers for meat tenderness |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | EP1238085B1 Bacillus thuringiensis toxin active against formicidae (ant) |
| 08/24/2005 | EP1194442B1 Method for carrying out the chromatographic fractionation of plasma or serum, preparations obtained thereby and their use |
| 08/24/2005 | EP1131078A4 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 08/24/2005 | EP1092036B1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 08/24/2005 | EP1088228B1 Cartilage resorption assays |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0681483B1 Compositions and methods for delivery of genetic material |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659440A Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659283A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659282A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659280A La1 - the genome of a lactobacillus strain |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659274A Cytokine receptor |
| 08/24/2005 | CN1659187A Ferritin fusion proteins for use in vaccines and other applications |
| 08/24/2005 | CN1659184A Prothrombin activating protein |
| 08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658899A Modified CEA nucleic acid and expression vectors |
| 08/24/2005 | CN1658896A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |